This episode covers the latest advancements in dermatology as Galderma unveils compelling interim results from their clinical trial at the J.P. Morgan Healthcare Conference. The trial evaluates a novel combination of Sculptra with Restylane Lyft or Contour to address facial volume loss from medication-induced weight loss, showing a 90% patient satisfaction rate. Gerry Muhle from Galderma discusses the rising aesthetic demands driven by weight-loss medications and the company's commitment to innovation. The episode also introduces RelabotulinumtoxinA, a new neuromodulator poised to impact the cosmetic industry, highlighting the evolving role of clinicians in supporting aesthetic and weight goals.
Stay connected with Dr. Teri Fisher and explore the latest in AI and automation for healthcare:
🎥 Watch on YouTube for in-depth AI tutorials: YouTube.com/@DrTeriFisher
📲 Follow on Instagram for automation tips: @DrTeriFisher
💡 Discover AI tools for your practice: DrTeriFisher.com
🎙 Listen to the long-form podcast: Anti-Aging Insights
👉 Subscribe to AI Automation Minute for your daily dose of AI-powered efficiency, and share with colleagues who want to work smarter, not harder!
#AIAutomationMinute #DrTeriFisher #HealthcareAI
